Last reviewed · How we verify
NCT07000721
Research on New Diagnosis and Treatment Technologies for Early Lung Cancer
NA trial testing Preoperative navigation path planning using the SARS-pro navigation system in Lung Cancer, Peripheral Pulmonary Nodules in 92 participants. Completed in 31 December 2024.
31 December 2024
Quick facts
| Lead sponsor | Jisong Zhang |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | diagnostic |
| Enrollment | 92 |
| Start date | 1 August 2023 |
| Primary completion | 31 December 2024 |
| Estimated completion | 31 December 2024 |
| Sites | 1 location across China |
Drugs / interventions tested
- Preoperative navigation path planning using the SARS-pro navigation system
- Preoperative navigation path planning using the VBN navigation system
Conditions studied
- Lung Cancer, Peripheral Pulmonary Nodules — all drugs for Lung Cancer, Peripheral Pulmonary Nodules →
Sponsor
Jisong Zhang
Who can join
Adults 18 to 80, any sex, with Lung Cancer, Peripheral Pulmonary Nodules. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To verify the clinical effectiveness and safety of the airway tree navigation system constructed by artificial intelligence (AI) in the navigation diagnosis of peripheral pulmonary nodules (PPLs).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07000721
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07000721 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Jisong Zhang
- Last refreshed: 8 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07000721.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing